Literature DB >> 20063189

Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.

Sang Yeob Lee1, Yong Min Jo, Won Tae Chung, Sung Hyun Kim, Seung Young Kim, Mee Sook Roh, Sung Won Lee.   

Abstract

Kaposi sarcoma (KS) is a vascular neoplasm mainly affecting the skin of the limbs that has previously been associated with rheumatoid arthritis (RA). When compared with the RA patients treated with corticosteroids and immunosuppressive drugs, the reported number of KS in RA patients was very rare. Although the exact mechanisms of developing KS in RA patients are unclear, some drugs which include corticosteroid have been suggested as an etiological factor in previous case reports of RA and KS. We report, here in, another case of KS associated with the initiation of leflunomide in a patient with RA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063189     DOI: 10.1007/s00296-009-1354-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  16 in total

1.  Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy.

Authors:  C D Cohen; S Horster; C A Sander; J R Bogner
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 2.  Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.

Authors:  P Casoli; B Tumiati
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

3.  Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.

Authors:  A S Chong; H Zeng; D A Knight; J Shen; G T Meister; J W Williams; W J Waldman
Journal:  Am J Transplant       Date:  2006-01       Impact factor: 8.086

4.  Kaposi's sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids.

Authors:  S R Weiner; D T Noritake; H E Paulus
Journal:  West J Med       Date:  1988-06

5.  Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide.

Authors:  D A Knight; A Q Hejmanowski; J E Dierksheide; J W Williams; A S Chong; W J Waldman
Journal:  Transplantation       Date:  2001-01-15       Impact factor: 4.939

6.  Detection of human herpesvirus-8 DNA in Kaposi's sarcomas from iatrogenically immunosuppressed patients.

Authors:  P L Rady; E Hodak; A Yen; O Memar; A Trattner; M Feinmesser; M David; S D Hudnall; S K Tyring
Journal:  J Am Acad Dermatol       Date:  1998-03       Impact factor: 11.527

7.  Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Authors:  W J Waldman; D A Knight; N S Lurain; D M Miller; D D Sedmak; J W Williams; A S Chong
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Kaposi's sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions.

Authors:  J P Larbre; J F Nicolas; P Collet; B Larbre; G Llorca
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

10.  Kaposi's sarcoma in rheumatoid arthritis.

Authors:  M W Schottstaedt; E R Hurd; M J Stone
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

View more
  2 in total

1.  Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.

Authors:  Alicja E Grzegorzewska; Dorota Frankiewicz; Danuta Bręborowicz; Irena Matławska; Wiesława Bylka
Journal:  Med Sci Monit       Date:  2012-08

2.  Oral Kaposi Sarcoma in HIV-seronegative Saudi patient: Literature review and case report.

Authors:  Asmaa Faden; Manal AlSheddi; Mohammed AlKindi; Lama Alabdulaaly
Journal:  Saudi Dent J       Date:  2017-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.